期刊文献+

广泛耐药鲍曼不动杆菌氨基糖苷类药物获得性耐药基因研究 被引量:5

The study of acquired resistant genes against aminoglycosides in extensively drug-resistant Acinetobacter baumannii
下载PDF
导出
摘要 目的了解重症监护病房(ICU)患者分离的广泛耐药(XDR)-鲍曼不动杆菌(AB)对氨基糖苷类药物获得性耐药基因情况。方法用phoenixTM-100全自动细菌鉴定药物敏感性分析仪对AB进行细菌鉴定和药物敏感性试验,gyrA和parC基因扩增测序确定AB。聚合酶链反应(PCR)测定20株XDR-AB的10种氨基糖苷类修饰酶基因、6种16S rRNA甲基化酶基因和外排泵adeB基因,并用DNA测序比对。结果 20株XDR-AB中,氨基糖苷类修饰酶基因aac(3)-Ⅰ、aac(6')-Ⅰb、ant(3″)-Ⅰ、aph(3')-Ⅰ检出率分别为90.0%、30.0%、95.0%、95.0%,而aac(3)-Ⅱ、aac(6')-Ⅰad、aac(6')-Ⅱ、ant(2″)-Ⅰ、ant(4')-Ⅰ及aph(3')-Ⅵa基因均未检出。armA型16S rRNA甲基化酶基因和外排泵adeB基因检出率均为100%。结论 20株XDR-AB均携带了armA和adeB基因,同时aac(3)-Ⅰ、ant(3″)-Ⅰ和aph(3)-Ⅰ检出率较高,提示ICU分离的XDR-AB对氨基糖苷类药物高水平耐药可能与携带的耐药基因有关。 Objective To investigate the situation of acquired resistant genes against aminoglycosidcs in extensively drug-resistant (XDR) Acintobacter baumannii (AB) isolated from intensive care unit (ICU) patients. Methods Bacterial identification and susceptibility tests of AB were performed by phoenixTM-100 automatic bacterial identification and susceptibility analyzer, and the AB identification was confirmed by gyrA and parC gene amplification sequencing. For the 20 isolates of XDR-AB, 10 aminoglyeoside modifying enzyme genes, 6 16S rRNA methylase genes and efflux pump adeB genes were detected by polymerase chain reaction(PCR) and verified and compared by DNA sequencing. Results Of the 20 isolates of XDR-AB, the detection rates of aac ( 3 ) - I , aac (6') - Ib, ant ( 3 ") - I and aph ( 3' ) - I genes were 90.0% , 30.0%, 95.0% and 95.0% , respectively. However, aac ( 3 ) - I1 , aac ( 6' ) - I ad , aac ( 6' ) - Ⅱ , ant (2")- I , ant (4')- I and aph (3')- Via genes were not found. In addition, the armA 16S rRNA methylase gene and efflux pump adeB genes existed in all of the 20 isolates, and the detection rates were 100%. Conclusions All of the 20 isolates of XDR-AB carry not only armA and adeB genes but also a large amount of aac( 3 ) - I ,ant(3") - I and aph( 3 ) - I genes. It indicates that the high-level resistance to aminoglycosides in XDR-AB isolated from ICU may be associated with the resistant genes.
出处 《检验医学》 CAS 2013年第11期1008-1011,共4页 Laboratory Medicine
关键词 广泛耐药鲍曼不动杆菌 氨基糖苷类修饰酶 获得性耐药基因 序列分析 Extensively drug-resistant Acintobacter baumannii Aminoglycoside modifying enzyme Acquiredresistant gene Sequencing analysis
  • 相关文献

参考文献12

二级参考文献72

共引文献479

同被引文献61

  • 1Durante-Mangoni E,Zarrilli R.Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance[J].Future Microbiol,2011,6(4):407-422.
  • 2Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing[S].M100-S18,CLSI,2008.
  • 3Peleg AY,Seifert H,Paterson DL.Acinetobacter baumannii: emergence of a successful pathogen[J].Clin Microbiol Rev,2008,21(3): 538-582.
  • 4Dijkshoorn L,Nemec A,Seifert H.An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii[J].Nat Rev Microbiol,2007,5(12): 939-951.
  • 5Vila J,Martí S,Sánchez-Céspedes J.Porins,efflux pumps and multidrug resistance in Acinetobacter baumannii[J].J Antimicrob Chemother,2007,59(6): 1210-1215.
  • 6Gordon NC,Wareham DW.Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance[J].Int J Antimicrob Agents,2010,35(3): 219-226.
  • 7Lee K,Yong D,Jeong SH,el al.Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens[J].Yonsei Med J,2011,52(6): 879-891.
  • 8Nordmann P,Naas T,Poirel L. Global spread of carbapenemase-pro- ducing enterohaeteriaceae [ J ]. Emerg Infect Dis, 2011,17 ( 10 ) : 1791 - 1797.
  • 9Nordmann P, Dortet L, Poirel L. Carbapenem resistance in enter- obacteriaceae:here is the storm [ J ]. Trends Mol Med, 2012, 18 (5) :263 -271.
  • 10Logan LK. Carbapenem-resistant enterobacteriaceae :an emerging prob- lem in children[J]. CAin Infect Dis,2012,55(6):852-859.

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部